Rare lephants
Screener

Bioxytran, Inc.

BIXT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-Q Aug 14, 2026 10-Q
8-K Aug 11, 2026 8-K
10-Q May 15, 2026 10-Q
10-K Apr 15, 2026 10-K
NT 10-K Apr 1, 2026 NT 10-K
8-K Mar 20, 2026 8-K
8-K Mar 13, 2026 8-K
8-K Mar 2, 2026 8-K
8-K Feb 17, 2026 8-K
8-K Feb 11, 2026 8-K
8-K Jan 5, 2026 8-K
8-K Dec 15, 2025 8-K
4 Nov 18, 2025 PRIMARY DOCUMENT
4 Nov 18, 2025 PRIMARY DOCUMENT
4 Nov 18, 2025 PRIMARY DOCUMENT
4 Nov 18, 2025 PRIMARY DOCUMENT
4/A Nov 18, 2025 PRIMARY DOCUMENT
4/A Nov 18, 2025 PRIMARY DOCUMENT
4/A Nov 18, 2025 PRIMARY DOCUMENT
10-Q Nov 14, 2025 10-Q
10-Q Aug 11, 2025 10-Q
10-Q May 15, 2025 10-Q
10-K Apr 3, 2025
8-K/A Apr 3, 2025
NT 10-K Mar 31, 2025
← Newer Page 1 of 19 · 469 filings Older →